Neurocrine Biosciences, Inc. - Common Stock (NQ: NBIX )
134.96
-0.46
(-0.34%)
Streaming Delayed Price
Updated: 9:50 AM EST, Dec 23, 2024
Add to My Watchlist
Price and Volume
Detailed QuoteVolume | 335,689 |
Open | 135.37 |
Bid (Size) | 134.90 (2) |
Ask (Size) | 135.31 (6) |
Prev. Close | 135.42 |
Today's Range | 134.91 - 136.11 |
52wk Range | 110.95 - 157.98 |
Shares Outstanding | 101,200,000 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Neurocrine Wins FDA Approval For Genetic Disorder Drug
December 13, 2024
Screening For Black Friday Bargains In The Stock Market
December 03, 2024
NASDAQ:NBIX qualifies as a high growth stock and is consolidating.
November 28, 2024
NASDAQ:NBIX—A High-Growth Stock Gearing Up for Its Next Upward Move.
September 19, 2024
Decoding 19 Analyst Evaluations For Neurocrine Biosciences
September 09, 2024
NASDAQ:NBIX, a growth stock which is not overvalued.
September 09, 2024
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins
September 30, 2024
Despite its growth, NASDAQ:NBIX remains within the realm of affordability.
September 30, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.